trending Market Intelligence /marketintelligence/en/news-insights/trending/p0vj0wknr-rikytrfudfyq2 content esgSubNav
In This List

Innovate Biopharmaceuticals appoints COO/chief medical officer

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Innovate Biopharmaceuticals appoints COO/chief medical officer

Innovate Biopharmaceuticals Inc. named June Almenoff as its chief medical officer and COO.

Almenoff is joining Innovate from RDD Pharma, a privately held gastrointestinal clinical-stage biopharma company, where she has been the chairperson since 2015.

She also served as president and chief medical officer of Furiex Pharmaceuticals Inc., a drug development company acquired by Allergan PLC in 2014.

Almenoff will lead the development of Innovate's pipeline including the upcoming phase 3 program for celiac disease.

Innovate Biopharmaceuticals is a Raleigh, N.C.-based clinical biotechnology company focused on developing autoimmune and inflammation therapeutics.